Skip to main content

Volume 18 Supplement 1

Proceedings from NextGen Therapies for SJIA & MAS – 2019

Proceedings

Publication of this supplement has been supported by the SJIA Foundation. The article has undergone the journal's standard peer review process for supplements. CS is the Editor-in-Chief of Pediatric Rheumatology. No other competing interests were declared.

Bethesda, MD, USA3-4 October 2019

Conference website

Edited by Charles Spencer.

  1. For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arth...

    Authors: Scott W. Canna, Grant S. Schulert, Adriana de Jesus, Alex Pickering, Hermine Brunner, Massimo Gadina, Stewart Levine, Raphaela Goldbach-Mansky, Jonathan Boutelle, Rashmi Sinha, Fabrizio DeBenedetti and Alexei Grom
    Citation: Pediatric Rheumatology 2020 18(Suppl 1):53
    Content type: Meeting report Published on:

Official journal of

  • New Content Item
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    3.0 - 5-year Impact Factor
    1.035 - SNIP (Source Normalized Impact per Paper)
    0.732 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    94 days submission to accept (Median)

    2023 Usage 
    1,095,144 downloads
    691 Altmetric mentions

Pediatric Rheumatology

ISSN: 1546-0096